Sedative antidepressants impair visual detection mechanisms in humans

Area of Science:

• Pharmacology
• Neuroscience
• Psychiatry

Background:

• Sedative antidepressants pose safety concerns, particularly regarding driving impairment.
• Selective serotonin re-uptake inhibitors (SSRIs) represent a newer class of antidepressants.
• Assessing the impact of antidepressants on psychomotor functions relevant to driving is crucial.

Purpose of the Study:

• To compare the effects of dothiepin (sedating antidepressant) and fluvoxamine (SSRI) on visual selective attention.
• To investigate driving-related psychomotor functions using the 'odd-ball' task.
• To determine if dothiepin or fluvoxamine impair focused and divided visual attention.

Main Methods:

• A study involving normal male volunteers.
• Utilized the 'odd-ball' task to assess visual selective attention (focused and divided).
• Subjects responded to central and/or peripheral letter targets presented on a screen.

Main Results:

• Dothiepin significantly delayed response times to single targets compared to fluvoxamine and placebo.
• Dothiepin primarily affected response times to peripheral targets.
• Both dothiepin and fluvoxamine delayed responses to central targets during divided attention trials.
• Response accuracy for peripheral targets was lower with both dothiepin and fluvoxamine compared to placebo.

Conclusions:

• Dothiepin impairs visual selective attention, potentially due to cholinergic or histaminergic blockade.
• The findings support the association between tricyclic antidepressants and increased risk of road traffic accidents.
• Further investigation is warranted in depressed patients using these antidepressant classes.